Skin Reactions Related to Thoracic Implantable Chamber Dressings

Recruiting now

Conditions studied: Skin Diseases

In brief

Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.

Key facts

Study ID

NCT07158879

Run by

Institut Curie

People needed

500

Starts

2025-06-10

Expected to finish

2026-12-10

Last updated by the study team

2025-09-08

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients over 18 years of age
• New chemotherapy patients (1st line of treatment only)
• Thoracic PAC

You may not qualify if…

• PICC Line and femoral PAC;
• Patients undergoing treatment with bi-specific antibodies (e.g. tebentafusp);
• Disunion requiring treatment
• Patients treated for hematological cancer;
• Persons deprived of their liberty or under guardianship (including curatorship);
• Adults under court protection;
• Inability to participate in the study for geographical, social or psychological reasons.
• No inclusion of persons covered by articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code (e.g. minors, protected adults, etc.).
• Opposition to data use

Where it is running

• Institut Curie — Paris, France (enrolling)
• Centre Hospitalier de Polynésie Française CHPF — Pirae, French Polynesia
• Hôpital Uturoa — Uturoa, French Polynesia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.